Summary

Michael Kenes is a Clinical Associate Professor in the Department of Clinical Pharmacy and the Clinical Pharmacy Specialist in the Critical Care Medicine Unit at Michigan Medicine. 

Dr. Kenes recieved his Doctor of Pharmacy from the University of Illinois Chicago and then completed his Pharmacy Practice Residency at the Cleveland Clinic and his Critical Care Pharmacy Residency at Vanderbilt University Medical Center. Dr. Kenes has previously served as a Clinical Pharmacy Specialist in the medical intensive care unit at Wake Forest Baptist Health. He attained Board Certification in Pharmacotherapy in 2014 and Critical Care Pharmacy in 2016. Dr. Kenes is actively involved in the Society of Critical Care Medicine and the American College of Clinical Pharmacy. His primary areas of research include critical care phamacotherapy and exploring ways to improve patient-centered outcomes during and after critical illness.

Awards

  • 2023 Fellow, American College of Critical Care Medicine
  • 2023 Evan Newport HOPE Award - for the Critical Care Medicine Unit where I am the pharmacy specialist, Michigan Medicine
  • 2022 Phi Delta Chi Faculty Teaching Award, P3 Class of 2023
  • 2021 Phi Delta Chi Faculty Teaching Award, P3 Class of 2022

Selected Publications

  • Kenes MT, McSparron JI, Marshall VD, Renius K, Hyzy RC. Propofol-Associated Hypertriglyceridemia in Coronavirus Disease 2019 versus Noncoronavirus Diease 2019 Acute Respiratory Distress Syndrome. Crit Care Explor. 2020;16:2(12):e0303.

  • Stringer KA, Puskarich MA, Kenes MT, Dickson RP. COVID-19: The Uninvited Guest in the Intensive Care Unit - Implications for Pharmacotherapy. Pharmacotherapy. 2020;40(5):382-6.

  • Goad NT, Bakhru RN, Pirkle JL, Kenes MT. Association of Hyperchloremia With Unfavorable Clinical Outcomes in Adults With Diabetic Ketoacidosis. J Intensive Care Med. 2019. PMID: 31342846.

  • Summers KL, Mihm AE, Kenes MT. Direct Oral Factor Xa Inhibitors in Patients with Morbid Obesity. Lancet Haematol. 2019. PMID: 31471006.

  • Bakhru RN, Davidson JF, Bookstaver RE, Kenes MT, Peters SP, Welborn KG, Creech O, Morris PE, Files DC. Implementation of an ICU Recovery Clinic at a Tertiary Care Academic Center. Crit Care Expl 2019;1(8):e0034.

  • Coe AB, Boostaver RE, Fritschle AC, Kenes MT, MacTavis P, Mohammad RA, Stollings JL. Pharmacists’ Perceptions on their Roles, Activities, Facilitators, and Barriers to Practicing in a Post-Intensive Care Recovery Clinic. Hospital Pharmacy Jan 2019. DOI: 10.1177/0018578718823740.

  • Bakhru RN, Davidson JF, Bookstaver RE, Kenes MT, Welborn KG, Morris PE, Files DC. Physical Function Impairment in Survivors of Critical Illness in an ICU Recovery Clinic. J Crit Care 2018;45:163-9.

  • Kenes MT, Stollings JL, Wang L, Girard TD, Ely EW, Pandharipande PP. Persistence of Delirium after Cessation of Sedatives and Analgesics and Impact on Clinical Outcomes in Critically Ill Patients. Pharmacotherapy. 2017;37(11):1357-65.

  • Kenes MT, Leonard MC, Bauer SR, Wyman MJ. Liposomal bupivacaine versus continuous infusion bupivacaine via an elastomeric pump for the treatment of postoperative pain. Am J Health Syst Pharm. 2015;72:S127-32.